April 4, 2018 / 12:43 PM / 7 months ago

BRIEF-Moleculin Announces Patients Treated In FDA Approved Phase I/Ii Annamycin Clinical Trial

April 4 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN ANNOUNCES PATIENTS TREATED IN FDA APPROVED PHASE I/II ANNAMYCIN CLINICAL TRIAL Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below